Cod Liver Oil.

Cod liver oil supplies vitamin D, which raises the body's output of vitamin K-dependent proteins such as osteocalcin and matrix Gla protein. Vitamin K2 carboxylates those proteins so they can bind calcium and direct it into bone and away from soft tissue.

The vitamin D in cod liver oil is converted to its active hormone form by hydroxylase enzymes in the liver and kidney, and those steps, together with the protein that carries vitamin D in the blood, depend on magnesium as a cofactor. When magnesium runs low that activation is slower, so adequate magnesium supports normal use of the vitamin D taken in.

The long-chain omega-3 fats in cod liver oil are polyunsaturated and oxidize easily, both in the bottle and in the body. Vitamin E is a fat-soluble antioxidant that dissolves in the same oil and interrupts that chain of lipid peroxidation, which is also why a higher polyunsaturated intake raises the body's vitamin E requirement.

Cod liver oil is one of the few foods that natively carries vitamin D3, so adding isolated cholecalciferol stacks on top of what the oil already supplies. The oil's long-chain fat also improves how much of the added D3 is absorbed.

The oil carries preformed vitamin A as retinyl esters in amounts that can dominate a formula's total. Because retinoic acid and calcitriol share the retinoid X receptor pool, that native vitamin A also tempers the oil's own vitamin D signalling.

Ascorbate in the aqueous phase regenerates the tocopheroxyl radical back to tocopherol, and tocopherol is what shields the oil's long-chain polyunsaturated fatty acids from chain peroxidation. The two antioxidants work as a relay.

Astaxanthin spans the lipid bilayer and quenches radicals at both ends, limiting peroxidation of EPA and DHA. It is used in marine oil formulas for stability as well as for its own activity.

Rosemary diterpenes such as carnosic acid are standard natural antioxidants for stabilising marine oils against rancidity during storage. The interaction is with the oil in the capsule rather than in the body.

The vitamin D3 the oil carries induces the intestinal calcium transport machinery, so calcium absorption rises with adequate D status. That is the mechanistic reason the two appear in the same bone formulas.

Free ferrous iron drives Fenton chemistry that initiates peroxidation of the oil's polyunsaturated chains. Putting an iron salt in the same capsule or dose with an unstabilised marine oil works against both ingredients.

The oil and the fat-soluble vitamins in it need bile salt micelles to cross the unstirred water layer and reach the enterocyte. Where bile flow is low, supplemental bile acids raise how much of the oil is taken up.

Long-chain omega-3s shift thromboxane production and lengthen bleeding time, and garlic's organosulfur compounds act on platelet aggregation by their own route. The effect on normal clotting adds, which is worth flagging on a label that carries both.

Ginkgolides act on platelet activating factor signalling while the oil's EPA changes the thromboxane to prostacyclin balance. Stacking them extends the effect on normal platelet function further than either alone.

Cod liver oil is delivered as triglycerides, which cannot cross the intestinal wall intact. Pancreatic lipase cleaves the fatty acids from positions one and three, leaving a monoglyceride that enters a bile-salt micelle. Where pancreatic output is low, undigested oil is what produces the oily stool and reflux people describe.

Both supply eicosapentaenoic and docosahexaenoic acid, so taking them together simply raises total intake of the same two fatty acids. The difference is that cod liver oil also carries retinol and vitamin D from the liver tissue while body-oil concentrates generally do not. Anyone combining them should count the total omega-3 dose and, separately, the total preformed vitamin A.

Krill delivers EPA and DHA bound largely to phospholipids rather than triglycerides, which changes the digestion step but not the fatty acids that arrive. Stacked with cod liver oil the omega-3 intake is cumulative. The phospholipid carrier is the argument for krill, not a different active.

Long-chain polyunsaturated fatty acids have many double bonds and are the most peroxidation-prone lipids in a membrane. Glutathione peroxidase, the enzyme that reduces lipid hydroperoxides, is a selenoprotein. Raising polyunsaturated intake therefore raises the workload on a selenium-dependent system, which is why the two are often discussed together.

Coenzyme Q10 is highly lipophilic and poorly absorbed from a dry powder taken without fat. Taking it in or alongside an oil provides the lipid the micelle step needs. The gain is largest for crystalline ubiquinone and smallest for preparations already dissolved in an oil base.

Carotenoid uptake rises when the same meal contains fat, because the pigments must partition into mixed micelles. An oil taken at the same time supplies that fat. This is a meal-composition effect and does not require the two to be in the same capsule.

Lutein absorption depends on dietary lipid for micelle formation and chylomicron packaging. Dosing it with an oil rather than on an empty stomach raises the fraction absorbed. At high combined doses the carotenoids compete with each other for the same micelles.

Beta-carotene needs fat to be absorbed and is then cleaved to retinal, entering the same vitamin A pool that the preformed retinol in cod liver oil feeds. Conversion of beta-carotene is regulated downward when retinoid status is already adequate, which is not true of preformed retinol. Total preformed vitamin A intake is the number to watch when both are used.

Phospholipid emulsifiers disperse the oil into fine droplets, increasing the surface area available to lipase and reducing the reflux people report with straight oil. Emulsified liquid preparations use this. It changes delivery, not the fatty acids delivered.

Long-chain omega-3 fatty acids shift eicosanoid production toward less aggregatory species and modestly lengthen bleeding time. Nattokinase has its own fibrinolytic activity. The effects are in the same direction, so the combination is one to mention to a clinician before any procedure rather than one to stack casually.

Salicin-derived salicylate inhibits platelet cyclooxygenase, and EPA competes with arachidonic acid at the same enzyme to yield the less aggregatory three-series thromboxane. Both nudge platelet aggregation in the same direction. Worth flagging rather than assuming it is additive in a useful way.

Curcumin has documented effects on platelet aggregation in laboratory work, and omega-3 fatty acids alter thromboxane production through substrate competition. Curcumin is also fat-soluble, so the oil aids its absorption. Both points are worth stating: an absorption gain and a clotting-direction overlap.

Phylloquinone is fat-soluble and its uptake is markedly higher when taken with a lipid-containing meal. Cod liver oil supplies that lipid. There is no competition at the downstream carrier level between the two.

Cod liver stores vitamin D, so the oil supplies cholecalciferol without anything being added. Stacking a separate vitamin D product on top makes the total intake the sum of both, and the amount in the oil varies by batch and by whether the manufacturer standardises it. Read both labels before assuming the doses are independent.